Invention Grant
- Patent Title: Lamotrigine oral liquid suspension and use thereof
-
Application No.: US15929929Application Date: 2020-05-29
-
Publication No.: US11596634B2Publication Date: 2023-03-07
- Inventor: Paul Sudhakar , Scott Boyer
- Applicant: OWP Pharmaceuticals, Inc.
- Applicant Address: US IL Naperville
- Assignee: OWP Pharmaceuticals, Inc.
- Current Assignee: OWP Pharmaceuticals, Inc.
- Current Assignee Address: US IL Naperville
- Agency: Carlson, Caspers, Vandenburgh & Lindquist P.A.
- Main IPC: A61K31/53
- IPC: A61K31/53 ; A61K47/06 ; A61K47/10 ; A61K9/00 ; A61K47/26 ; A61K47/38 ; A61K47/36 ; A61K47/02 ; A61K47/34
Abstract:
The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
Public/Granted literature
- US20200375995A1 LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF Public/Granted day:2020-12-03
Information query
